A Neurologist ’s Perspective on Understanding Myasthenia Gravis
Myasthenia gravis (MG) is a disease of neuromuscular transmission caused by antibodies directed toward proteins concentrated at the neuromuscular junction. Mild to life-threatening weakness varies in severity over time and with level of activity. Therefore, clinical diagnosis is often challenging. MG may be categorized by autoantibody type, thymic pathologic condition, and age of onset. Treatments are tailored for each group. A key management concern is severe exacerbation of weakness resulting from infections or exposure to certain medications, including antibiotics, which may be severe enough to produce respiratory decompensation. The article reviews key diagnostic issues and treatment options.
Source: Thoracic Surgery Clinics - Category: Cardiovascular & Thoracic Surgery Authors: Loulwah Mukharesh, Henry J. Kaminski Source Type: research
More News: Brain | Cardiovascular & Thoracic Surgery | Myasthenia Gravis | Neurology | Neurosurgery | Respiratory Medicine